Delivra Health Brands Inc.
DHBUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $6 | $6 | $5 |
| - Cash | $2 | $3 | $3 | $4 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $7 | $5 | $5 | $4 |
| Revenue | $2 | $4 | $3 | $3 |
| % Growth | -47.2% | 40.8% | 12.4% | – |
| Gross Profit | $1 | $2 | $2 | $1 |
| % Margin | 46% | 53.6% | 50.1% | 47% |
| EBITDA | $0 | $1 | -$0 | -$0 |
| % Margin | 0.3% | 14.9% | -1% | -14.1% |
| Net Income | -$0 | $1 | -$0 | -$1 |
| % Margin | -2.8% | 19.2% | -13.6% | -29.5% |
| EPS Diluted | -0.002 | 0.012 | -0.014 | -0.026 |
| % Growth | -117.2% | 190.4% | 48.1% | – |
| Operating Cash Flow | -$0 | $0 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$1 | -$0 |